INS and liver dysplastic nodule: Combined therapy with RESV (20 mg/(kg/day)) and insulin can lead to maximum improvements in DN due to the hypoglycemic effect of insulin and the ability of both drugs to increase the activity of antioxidant enzymes in the renal cortex, inhibit LPO and activate Na+/K+−ATPase, independently of each other [132].